Skip to main content

Table 2 Crude and adjusted treatment outcomes

From: Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania

Treatment outcome ALU (N = 114) DHP (N = 89)
ETF 0 (0%) 0 (0%)
LCF, n (%) 1 (0.88%) 0 (0%)
LPF, n (%) 5 (4.39%) 1 (1.12%)
ACPR, n (%) 108 (94.74%) 88 (98.88%)
PCR corrected   
 ETF 0 0
 LCF, n (%) 1 (0.88) 0
 LPF, n (%) 4 (3.54) 1 (1.12)
 ACPR, n (%) 109 (95.58) 88 (98.88)
Parasite persistence   
Positive blood smear   
 Day 1, n (%) 50 (43.10) 36 (40.45)
 Day 2, n (%) 3 (2.59) 1 (1.12)
 Day 3, n (%) 0 0